Google News – Pharmaceuticals External News
Regulatory & Compliance Articles
Google News – Biopharma External News
iX Biopharma closes in on US military approval for pain drug - The Business Times
Google News – Biopharma External News
iX Biopharma announces major US regulatory development for Wafermine; US govt opens emergency use pathway - The Edge Singapore
Google News – Clinical Trials External News
US FDA Clears Acepodia’s ACE723 IND for Phase I Trial in Liver Cancer - BioPharma APAC
Google News – Clinical Trials External News
FDA Guidance Expands Cancer Trial Eligibility, Reshaping Feasibility Models - The Clinical Trial Vanguard
Google News – Pharmaceuticals External News
ACADIA Pharmaceuticals (ACAD) Wins EU Approval For DAYBU, Is The 16% Upside Still There? - simplywall.st
Google News – FDA (biotech/pharma) External News
AstraZeneca’s Etcamah combo approved by FDA - The Pharma Letter
Google News – Pharmaceuticals External News
Does Pelacarsen’s Phase 3 Miss And ZANVASTRO’s FDA Win Change The Bull Case For Ionis (IONS)? - simplywall.st
Google News – Medical Devices External News
CBIC Issues Mandatory Compliance Checklists for Import of Cosmetics, Drugs and Medical Devices - Taxscan
Google News – FDA (biotech/pharma) External News
CRISPR Therapeutics gains FDA approval for CASG... - Pluang
Google News – FDA (biotech/pharma) External News
FDA backs AstraZeneca's oral SERD despite adcom concerns - FirstWord Pharma
Google News – Biopharma External News
Matinas BioPharma Receives Notice of Non-Compliance with NYSE American Continued Listing Standards - The Manila Times
Google News – Biopharma External News
Matinas BioPharma Receives NYSE American Noncompliance Notice for Continued Listing Standards - Quiver Quantitative
Google News – Clinical Trials External News
This Week at FDA: Foreign clinical trial scrutiny, botanical drugs, and an EUA declaration - RAPS
Google News – Biopharma External News